| pubmed-article:11064359 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11064359 | lifeskim:mentions | umls-concept:C0079427 | lld:lifeskim |
| pubmed-article:11064359 | lifeskim:mentions | umls-concept:C0029925 | lld:lifeskim |
| pubmed-article:11064359 | lifeskim:mentions | umls-concept:C0080055 | lld:lifeskim |
| pubmed-article:11064359 | lifeskim:mentions | umls-concept:C0596611 | lld:lifeskim |
| pubmed-article:11064359 | lifeskim:mentions | umls-concept:C0237881 | lld:lifeskim |
| pubmed-article:11064359 | lifeskim:mentions | umls-concept:C0220901 | lld:lifeskim |
| pubmed-article:11064359 | lifeskim:mentions | umls-concept:C0750502 | lld:lifeskim |
| pubmed-article:11064359 | pubmed:issue | 9 | lld:pubmed |
| pubmed-article:11064359 | pubmed:dateCreated | 2000-11-16 | lld:pubmed |
| pubmed-article:11064359 | pubmed:abstractText | The prognostic significance and nature of p53 dysfunction in ovarian carcinoma is unclear. The relation between p53 overexpression, p53 mutations, and their effects on overall survival in primary ovarian carcinoma is explored. | lld:pubmed |
| pubmed-article:11064359 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11064359 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11064359 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:11064359 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11064359 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:11064359 | pubmed:issn | 0008-543X | lld:pubmed |
| pubmed-article:11064359 | pubmed:author | pubmed-author:SoodA KAK | lld:pubmed |
| pubmed-article:11064359 | pubmed:author | pubmed-author:HughesJ HJH | lld:pubmed |
| pubmed-article:11064359 | pubmed:author | pubmed-author:BullerR ERE | lld:pubmed |
| pubmed-article:11064359 | pubmed:author | pubmed-author:ShahinM SMS | lld:pubmed |
| pubmed-article:11064359 | pubmed:copyrightInfo | Copyright 2000 American Cancer Society. | lld:pubmed |
| pubmed-article:11064359 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11064359 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:11064359 | pubmed:volume | 89 | lld:pubmed |
| pubmed-article:11064359 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11064359 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11064359 | pubmed:pagination | 2006-17 | lld:pubmed |
| pubmed-article:11064359 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:11064359 | pubmed:meshHeading | pubmed-meshheading:11064359... | lld:pubmed |
| pubmed-article:11064359 | pubmed:meshHeading | pubmed-meshheading:11064359... | lld:pubmed |
| pubmed-article:11064359 | pubmed:meshHeading | pubmed-meshheading:11064359... | lld:pubmed |
| pubmed-article:11064359 | pubmed:meshHeading | pubmed-meshheading:11064359... | lld:pubmed |
| pubmed-article:11064359 | pubmed:meshHeading | pubmed-meshheading:11064359... | lld:pubmed |
| pubmed-article:11064359 | pubmed:meshHeading | pubmed-meshheading:11064359... | lld:pubmed |
| pubmed-article:11064359 | pubmed:meshHeading | pubmed-meshheading:11064359... | lld:pubmed |
| pubmed-article:11064359 | pubmed:meshHeading | pubmed-meshheading:11064359... | lld:pubmed |
| pubmed-article:11064359 | pubmed:meshHeading | pubmed-meshheading:11064359... | lld:pubmed |
| pubmed-article:11064359 | pubmed:meshHeading | pubmed-meshheading:11064359... | lld:pubmed |
| pubmed-article:11064359 | pubmed:meshHeading | pubmed-meshheading:11064359... | lld:pubmed |
| pubmed-article:11064359 | pubmed:meshHeading | pubmed-meshheading:11064359... | lld:pubmed |
| pubmed-article:11064359 | pubmed:meshHeading | pubmed-meshheading:11064359... | lld:pubmed |
| pubmed-article:11064359 | pubmed:meshHeading | pubmed-meshheading:11064359... | lld:pubmed |
| pubmed-article:11064359 | pubmed:meshHeading | pubmed-meshheading:11064359... | lld:pubmed |
| pubmed-article:11064359 | pubmed:meshHeading | pubmed-meshheading:11064359... | lld:pubmed |
| pubmed-article:11064359 | pubmed:meshHeading | pubmed-meshheading:11064359... | lld:pubmed |
| pubmed-article:11064359 | pubmed:meshHeading | pubmed-meshheading:11064359... | lld:pubmed |
| pubmed-article:11064359 | pubmed:year | 2000 | lld:pubmed |
| pubmed-article:11064359 | pubmed:articleTitle | The prognostic significance of p53 tumor suppressor gene alterations in ovarian carcinoma. | lld:pubmed |
| pubmed-article:11064359 | pubmed:affiliation | Department of Obstetrics and Gynecology, University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA. | lld:pubmed |
| pubmed-article:11064359 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11064359 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11064359 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11064359 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11064359 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11064359 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11064359 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11064359 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11064359 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11064359 | lld:pubmed |
